Since the inaugural program in November 2007, CBI’s PRO Franchise has evolved into a reliable and thought-provoking platform for the latest and greatest insights related to patient reported outcomes.
After exploring the intricacies of FDA’s final Guidance at CBI and ISOQOL’s joint effort in May of 2010, the 7th Patient Reported Outcomes Conference is poised to generate our most advanced discussion to-date.

|
Don’t miss your opportunity to leverage industry experience and benefit from shared networking opportunities with CBI’s 4th Comparative Effectiveness Research Summit.
|
For more information, please contact Kevin Palmaccio at 339-298-2101 or email him at kevin.palmaccio@cbinet.com.
Hear what some of our previous attendees had to say:
New Page 1
“Probably the best PRO conference I have ever attended.”
- Ari Gnanasakthy,
Head of PRO Excellence, Novartis
“High quality, inspiring and insightful conference that pinpoints important
topics in the field of PRO.”
- Jennie Medin, HEOR
Scientist, Astrazeneca
“A
focused PRO workshop with presentations relevant to testing and interpreting PRO
measures.”
- Anuprita Patkar,
Assistant Director, HEOR, Ethicon
“A
great workshop. Very effective and efficient PRO conference in two days.”
- Nalin
Payakachat, UAMS College of Pharmacy
“The participants and the vendors seemed very informed and knowledgeable. This
conference was certainly a high-level audience and participants.”
- Kimberly Miller, Senior
Project Manager, ICON
“Great dialogue on up the minute topics in our field.”
-
Jennifer Hanlon, Senior Analyst, QM, Inc.
Sponsors/Exhibitors:
 |
EPI-Q is a scientific agency and consultancy dedicated to providing novel research, strategic direction, and communication solutions that uncover the true value of healthcare innovation. EPI-Q creates opportunities to build and enhance platforms for growth. Since its inception in 1994, EPI-Q has assisted Fortune 100 biopharmaceutical and medical device firms facilitate market access and optimize pricing and reimbursement by demonstrating the clinical and economic benefits of medical therapies and technologies. EPI-Q is unique with its staff of resident experts who have been front line healthcare practitioners and decision makers — treating and educating patients, implementing practice guidelines, executing quality improvement initiatives, and assuring access to evidence-based care. With its global network spanning the payer, provider, policy and academic communities, EPI-Q can tailor strategies, execute research, and develop programs in the most effective, efficient and customized way.
|

|
 |

|
|
 |
|
|
|
For more information or to register, please contact the Center for Business Intelligence toll free by phone at 1-800-817-8601 or via e-mail at cbireg@cbinet.com.
|